76 related articles for article (PubMed ID: 10597312)
1. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation.
Liu X; Baker E; Eyre HJ; Sutherland GR; Zhou M
Oncogene; 1999 Nov; 18(50):7110-4. PubMed ID: 10597312
[TBL] [Abstract][Full Text] [Related]
2. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line.
Wang XZ; Jolicoeur EM; Conte N; Chaffanet M; Zhang Y; Mozziconacci MJ; Feiner H; Birnbaum D; Pébusque MJ; Ron D
Oncogene; 1999 Oct; 18(41):5718-21. PubMed ID: 10523851
[TBL] [Abstract][Full Text] [Related]
3. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
Schaefer G; Fitzpatrick VD; Sliwkowski MX
Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
[TBL] [Abstract][Full Text] [Related]
4. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M
Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145
[TBL] [Abstract][Full Text] [Related]
5. Gamma-heregulin has no biological significance in primary breast cancer.
Sánchez-Valdivieso EA; Cruz JJ; Salazar R; del Mar Abad M; Gómez-Alonso A; Gómez A; González-Sarmiento R
Br J Cancer; 2002 Apr; 86(8):1362-3. PubMed ID: 11953899
[No Abstract] [Full Text] [Related]
6. Chromosome translocations in breast cancer with breakpoints at 8p12.
Courtay-Cahen C; Morris JS; Edwards PA
Genomics; 2000 May; 66(1):15-25. PubMed ID: 10843800
[TBL] [Abstract][Full Text] [Related]
7. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.
Adélaïde J; Chaffanet M; Mozziconacci MJ; Popovici C; Conte N; Fernandez F; Sobol H; Jacquemier J; Pébusque M; Ron D; Lafage-Pochitaloff M; Birnbaum D
Int J Oncol; 2000 Apr; 16(4):683-8. PubMed ID: 10717235
[TBL] [Abstract][Full Text] [Related]
8. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA
Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574
[TBL] [Abstract][Full Text] [Related]
9. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
10. Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene.
Zhang X; Tsao H; Tsuji T; Minoshima S; McBride J; Majewski P; Todd R; Shimizu N; Wong DT; Housman DE; Haluska FG
Biochem Biophys Res Commun; 1999 Feb; 255(1):59-63. PubMed ID: 10082655
[TBL] [Abstract][Full Text] [Related]
11. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
12. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
13. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
Ram TG; Schelling ME; Hosick HL
Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
[TBL] [Abstract][Full Text] [Related]
14. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
[TBL] [Abstract][Full Text] [Related]
15. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
[TBL] [Abstract][Full Text] [Related]
16. Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins.
Medina-Kauwe LK; Maguire M; Kasahara N; Kedes L
Gene Ther; 2001 Dec; 8(23):1753-61. PubMed ID: 11803394
[TBL] [Abstract][Full Text] [Related]
17. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
[TBL] [Abstract][Full Text] [Related]
18. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
Menendez JA; Mehmi I; Lupu R
Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
[TBL] [Abstract][Full Text] [Related]
19. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
20. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
